Parkinsonism-plus syndromes (Q38634983)

5 September 2017

1 reference

title

Parkinsonism-plus syndromes (English)

1 reference

5 September 2017

1 reference

Jankovic J

1

1 reference

PubMed ID

2657411

5 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

5 September 2017

1 reference

5 September 2017

4 Suppl 1

1 reference

5 September 2017

S95-119

1 reference

The heterogeneity of Parkinson's disease: clinical and prognostic implications.

5 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Hereditary dystonia-parkinsonism syndrome of juvenile onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Flunarizine- and cinnarizine-induced extrapyramidal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Elevated manganese levels associated with dementia and extrapyramidal signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

A pure parkinsonian syndrome following acute carbon monoxide intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Delayed neurologic sequelae in carbon monoxide intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Cyanide-induced parkinsonism: a clinicopathologic report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Basal ganglia calcification, hypoparathyroidism, and extrapyramidal motor manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Calcification of the basal ganglia as a cause of levodopa-resistant parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Parkinsonism and basal ganglia infarcts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Neurologic aspects of boxing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Normal pressure hydrocephalus and hypertensive cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Treatment of progressive supranuclear palsy with tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Methysergide in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Shy-Drager syndrome: neuronal loss depends on size, function, and topography in ventral spinal outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Amyotrophic lateral sclerosis on Guam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Corticodentatonigral Degeneration With Neuronal Achromasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Parkinson's disease in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

New form of familial Parkinson-dementia syndrome: clinical and pathologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870040512

21 January 2018

Identifiers

DOI

10.1002/MDS.870040512

1 reference

5 September 2017

1 reference

PubMed ID

2657411